Literature DB >> 6601266

Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

P A Shurin, C D Marchant, C H Kim, G F Van Hare, C E Johnson, M A Tutihasi, L J Knapp.   

Abstract

We performed a prospective study to monitor changes in the bacterial etiology of acute otitis media. Branhamella catarrhalis was isolated from middle ear exudates of 3 of 47 children (6.4%) studied between September 1979 and September 1980 and from 26 of 98 children (26.5%) studied between October 1980 and February 1982 (P = 0.0055). Twenty of 26 B. catarrhalis strains (76.9%) were found to be resistant to ampicillin and to produce beta-lactamase. In contrast only 2 of 26 strains of Haemophilus influenzae (7.7%) isolated from the same group of patients were resistant to ampicillin. We could not detect changes in culture methods, in demographic features, in patterns of medical care or in prior middle ear disease or antimicrobial drug usage, which might explain this striking increase in the relative importance of resistant strains of B. catarrhalis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601266     DOI: 10.1097/00006454-198301000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  31 in total

Review 1.  The use of oral antibiotics in daily clinical practice.

Authors:  A Verghese
Journal:  Drugs       Date:  1991       Impact factor: 9.546

2.  Moraxella catarrhalis Might Be More Common than Expected in Acute Otitis Media in Young Finnish Children.

Authors:  Saara Sillanpää; Sami Oikarinen; Markku Sipilä; Lenka Kramna; Markus Rautiainen; Heini Huhtala; Janne Aittoniemi; Jussi Laranne; Heikki Hyöty; Ondrej Cinek
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

3.  Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.

Authors:  I Luman; R W Wilson; R J Wallace; D R Nash
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 4.  Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors:  G V Doern; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 7.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Otitis media and sinusitis in children. Role of Branhamella catarrhalis.

Authors:  C D Bluestone
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.

Authors:  J Sarwar; A A Campagnari; C Kirkham; T F Murphy
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.